강직성척추염에서 TNF 차단제와 포도막염 = TNF Inhibitors and Uveitis in Ankylosing Spondylitis

다국어 초록 (Multilingual Abstract)

Uveitis is the most common extra-articular manifestation of ankylosing spondylitis, and this occurs in 30∼50% of the patients with ankylosing spondylitis. The main symptoms of ankylosing spondylitis are usually highly responsive to TNF inhibitors, but the effects of TNF inhibitors on uveitis are inconsistent. We report here on sixteen cases of new onset uveitis during etanercept therapy in patients with ankylosing spondylitis and they had no histories of uveitis. The symptoms of ankylosing spondyltiis, other than the uveitis, were well controlled during etanercept therapy. Six patients had histories of infliximab therapy before undergoing etanercept therapy, and uveitis did not develop during this infliximab therapy. Uveitis can develop during the course of ankylosing spondylitis, yet there is a possibility of a temporal relationship between etanercept therapy and uveitis.

참고문헌 (Reference)

1 Coates LC, "Uveitis and tumour necrosis factor blockade in ankylosing spondylitis" 67 : 729-730, 2008

2 Zou J, "Up regulation of the production of tumour necrosis factor alpha and interferon gamma by T cells in ankylosing spondylitis during treatment with etanercept" 62 : 561-564, 2003

3 Furst DE, "Tumor necrosis factor antagonists: different kinetics and/or mechanisms of action may explain differences in the risk for developing granulomatous infection" 36 : 159-167, 2006

4 Gorman JD, "Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha" 346 : 1349-1356, 2002

5 Monnet D, "Severe uveitis in an HLA-B27-positive patient with ankylosing spondylitis" 2 : 393-397, 2006

6 Zeboulon N, "Prevalence and characteristics of uveitis in the spondyloarthropathies: a systematic literature review" 67 : 955-959, 2008

7 Tiliakos AN, "Ocular inflammatory disease in patients with RA taking etanercept: is discontinuation of etanercept necessary?" 30 : 2727-, 2003

8 Van den Brande JM, "Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease" 124 : 1774-1785, 2003

9 Rosenbaum JT, "Effect of etanercept on iritis in patients with ankylosing spondylitis" 50 : 3736-3737, 2004

10 Zou J, "Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab" 48 : 780-790, 2003

11 Reddy AR, "Does etanercept induce uveitis?" 87 : 925-, 2003

12 Lim LL, "Do tumor necrosis factor inhibitors cause uveitis? A registry- ased study" 56 : 3248-3252, 2007

13 Dinarello CA, "Differences between anti-tumor necrosis factor-alpha monoclonal antibodies and soluble TNF receptors in host defense impairment" 74 : 40-47, 2005

14 Scallon B, "Binding and functional comparisons of two types of tumor necrosis factor antagonists" 301 : 418-426, 2002

15 Braun J, "Anti-tumour necrosis factor alpha therapy for ankylosing spondylitis: international experience" 61 (61): 351-360, 2002